Cargando…

Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia

X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; althou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariganello, Paola, Angelino, Giulia, Scarselli, Alessia, Salfa, Irene, Della Corte, Martina, De Matteis, Arianna, D'Argenio, Patrizia, Livadiotti, Susanna, Manno, Emma C., Russo, Cristina, Finocchi, Andrea, Cancrini, Caterina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686078/
https://www.ncbi.nlm.nih.gov/pubmed/23862092
http://dx.doi.org/10.1155/2013/735108
_version_ 1782273753657376768
author Ariganello, Paola
Angelino, Giulia
Scarselli, Alessia
Salfa, Irene
Della Corte, Martina
De Matteis, Arianna
D'Argenio, Patrizia
Livadiotti, Susanna
Manno, Emma C.
Russo, Cristina
Finocchi, Andrea
Cancrini, Caterina
author_facet Ariganello, Paola
Angelino, Giulia
Scarselli, Alessia
Salfa, Irene
Della Corte, Martina
De Matteis, Arianna
D'Argenio, Patrizia
Livadiotti, Susanna
Manno, Emma C.
Russo, Cristina
Finocchi, Andrea
Cancrini, Caterina
author_sort Ariganello, Paola
collection PubMed
description X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; although they are especially due to encapsulated bacteria, a specific association with Campylobacter species has been reported. Here, we report the case of a boy with XLA who presented with relapsing Campylobacter jejuni systemic infections. His clinical history supports the hypothesis of the persistence of C. jejuni in his intestinal tract. Indeed, as previously reported, XLA patients may become chronic intestinal carriers of Campylobacter, even in absence of symptoms, with an increased risk of relapsing bacteraemia. The humoral defect is considered to be crucial for this phenomenon, as well as the difficulties to eradicate the pathogen with an appropriate antibiotic therapy; drug resistance is raising in Campylobacter species, and the appropriate duration of treatment has not been established. C. jejuni should always be suspected in XLA patients with signs and symptoms of systemic infection, and treatment should be based on antibiogram to assure the eradication of the pathogen.
format Online
Article
Text
id pubmed-3686078
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-36860782013-07-16 Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia Ariganello, Paola Angelino, Giulia Scarselli, Alessia Salfa, Irene Della Corte, Martina De Matteis, Arianna D'Argenio, Patrizia Livadiotti, Susanna Manno, Emma C. Russo, Cristina Finocchi, Andrea Cancrini, Caterina Case Rep Pediatr Case Report X-linked agammaglobulinemia (XLA) is a primary immunodeficiency of the humoral compartment, due to a mutation in the Bruton tyrosine kinase (BTK) gene, characterized by a severe defect of circulating B cells and serum immunoglobulins. Recurrent infections are the main clinical manifestations; although they are especially due to encapsulated bacteria, a specific association with Campylobacter species has been reported. Here, we report the case of a boy with XLA who presented with relapsing Campylobacter jejuni systemic infections. His clinical history supports the hypothesis of the persistence of C. jejuni in his intestinal tract. Indeed, as previously reported, XLA patients may become chronic intestinal carriers of Campylobacter, even in absence of symptoms, with an increased risk of relapsing bacteraemia. The humoral defect is considered to be crucial for this phenomenon, as well as the difficulties to eradicate the pathogen with an appropriate antibiotic therapy; drug resistance is raising in Campylobacter species, and the appropriate duration of treatment has not been established. C. jejuni should always be suspected in XLA patients with signs and symptoms of systemic infection, and treatment should be based on antibiogram to assure the eradication of the pathogen. Hindawi Publishing Corporation 2013 2013-06-03 /pmc/articles/PMC3686078/ /pubmed/23862092 http://dx.doi.org/10.1155/2013/735108 Text en Copyright © 2013 Paola Ariganello et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Ariganello, Paola
Angelino, Giulia
Scarselli, Alessia
Salfa, Irene
Della Corte, Martina
De Matteis, Arianna
D'Argenio, Patrizia
Livadiotti, Susanna
Manno, Emma C.
Russo, Cristina
Finocchi, Andrea
Cancrini, Caterina
Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title_full Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title_fullStr Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title_full_unstemmed Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title_short Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
title_sort relapsing campylobacter jejuni systemic infections in a child with x-linked agammaglobulinemia
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686078/
https://www.ncbi.nlm.nih.gov/pubmed/23862092
http://dx.doi.org/10.1155/2013/735108
work_keys_str_mv AT ariganellopaola relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT angelinogiulia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT scarsellialessia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT salfairene relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT dellacortemartina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT dematteisarianna relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT dargeniopatrizia relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT livadiottisusanna relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT mannoemmac relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT russocristina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT finocchiandrea relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia
AT cancrinicaterina relapsingcampylobacterjejunisystemicinfectionsinachildwithxlinkedagammaglobulinemia